GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Asset Turnover

Livzon Pharmaceutical Group (SZSE:000513) Asset Turnover : 0.13 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Livzon Pharmaceutical Group's Revenue for the three months ended in Mar. 2024 was ¥3,243 Mil. Livzon Pharmaceutical Group's Total Assets for the quarter that ended in Mar. 2024 was ¥25,117 Mil. Therefore, Livzon Pharmaceutical Group's Asset Turnover for the quarter that ended in Mar. 2024 was 0.13.

Asset Turnover is linked to ROE % through Du Pont Formula. Livzon Pharmaceutical Group's annualized ROE % for the quarter that ended in Mar. 2024 was 16.97%. It is also linked to ROA % through Du Pont Formula. Livzon Pharmaceutical Group's annualized ROA % for the quarter that ended in Mar. 2024 was 9.68%.


Livzon Pharmaceutical Group Asset Turnover Historical Data

The historical data trend for Livzon Pharmaceutical Group's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Asset Turnover Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.55 0.56 0.54 0.50

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.12 0.11 0.13

Competitive Comparison of Livzon Pharmaceutical Group's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Asset Turnover falls into.



Livzon Pharmaceutical Group Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Livzon Pharmaceutical Group's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=12430.038/( (24868.169+25044.827)/ 2 )
=12430.038/24956.498
=0.50

Livzon Pharmaceutical Group's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=3242.815/( (25044.827+25189.696)/ 2 )
=3242.815/25117.2615
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Livzon Pharmaceutical Group  (SZSE:000513) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Livzon Pharmaceutical Group's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=2431.296/14324.3285
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2431.296 / 12971.26)*(12971.26 / 25117.2615)*(25117.2615/ 14324.3285)
=Net Margin %*Asset Turnover*Equity Multiplier
=18.74 %*0.5164*1.7535
=ROA %*Equity Multiplier
=9.68 %*1.7535
=16.97 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Livzon Pharmaceutical Group's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=2431.296/25117.2615
=(Net Income / Revenue)*(Revenue / Total Assets)
=(2431.296 / 12971.26)*(12971.26 / 25117.2615)
=Net Margin %*Asset Turnover
=18.74 %*0.5164
=9.68 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Livzon Pharmaceutical Group Asset Turnover Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines